loadpatents
name:-0.015015125274658
name:-0.012414932250977
name:-0.0035269260406494
Bradner; James Elliott Patent Filings

Bradner; James Elliott

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bradner; James Elliott.The latest application filed is for "compositions and methods for treating neoplasia, inflammatory disease and other disorders".

Company Profile
3.10.15
  • Bradner; James Elliott - Weston MA
  • Bradner; James Elliott - Cambridge MA
  • Bradner; James Elliott - Boston MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Compositions and methods for treating leukemia
Grant 10,676,484 - Bradner , et al.
2020-06-09
Compositions And Methods For Treating Neoplasia, Inflammatory Disease And Other Disorders
App 20200148702 - Bradner; James Elliott ;   et al.
2020-05-14
Compositions and methods for treating neoplasia, inflammatory disease and other disorders
Grant 10,407,441 - Bradner , et al. Sept
2019-09-10
Compositions And Methods For Treating Neoplasia, Inflammatory Disease And Other Disorders
App 20180237454 - Bradner; James Elliott ;   et al.
2018-08-23
Compositions And Methods For Treating Leukemia
App 20180222917 - Bradner; James Elliott ;   et al.
2018-08-09
Compositions and methods for treating leukemia
Grant 9,815,849 - Bradner , et al. November 14, 2
2017-11-14
Male contraceptive compositions and methods of use
Grant 9,789,120 - Bradner , et al. October 17, 2
2017-10-17
Compositions and Methods for Treating Neoplasia, Inflammatory Disease and Other Disorders
App 20170029437 - Bradner; James Elliott ;   et al.
2017-02-02
LNA antisense oligonucleotides for the modulation of Myc expression
Grant 9,506,060 - Bandaru , et al. November 29, 2
2016-11-29
Male Contraceptive Compositions And Methods Of Use
App 20160317547 - Bradner; James Elliott ;   et al.
2016-11-03
Compositions and methods for treating neoplasia, inflammatory disease and other disorders
Grant 9,320,741 - Bradner , et al. April 26, 2
2016-04-26
Male contraceptive compositions and methods of use
Grant 9,301,962 - Bradner , et al. April 5, 2
2016-04-05
Lna Antisense Oligonucleotides For The Modulation Of Myc Expression
App 20160024495 - Bandaru; Rajanikanth ;   et al.
2016-01-28
Compositions and Methods for Treating Neoplasia, Inflammatory Disease and Other Disorders
App 20150150885 - Bradner; James Elliott ;   et al.
2015-06-04
Compositions and methods for treating neoplasia, inflammatory disease and other disorders
Grant 8,981,083 - Bradner , et al. March 17, 2
2015-03-17
Compositions and Methods for Treating Leukemia
App 20140011862 - Bradner; James Elliott ;   et al.
2014-01-09
Compositions And Methods For Modulating Metabolism
App 20130252331 - Bradner; James Elliott ;   et al.
2013-09-26
Male Contraceptive Compositions and Methods of Use
App 20130210813 - Bradner; James Elliott ;   et al.
2013-08-15
Compositions And Methods For Treating Neoplasia, Inflammatory Disease And Other Disorders
App 20130184264 - Bradner; James Elliott ;   et al.
2013-07-18
Treatment of protein degradation disorders
App 20060239909 - Anderson; Kenneth C. ;   et al.
2006-10-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed